NCT06342037 NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial Status RECRUITING Phase PHASE2
NCT06338644 Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients. Status NOT_YET_RECRUITING Phase N/A
NCT06328387 HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06324357 Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread Status RECRUITING Phase PHASE1/PHASE2
NCT06321666 Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone Status ACTIVE_NOT_RECRUITING Phase NA
NCT06320392 Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast Cancer Status COMPLETED Phase N/A
NCT06308939 Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial Status NOT_YET_RECRUITING Phase PHASE2
NCT06263543 Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC Status RECRUITING Phase PHASE2
NCT06253195 BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06246968 A Study of Pembrolizumab and Cryoablation in People With Breast Cancer Status RECRUITING Phase PHASE1
NCT06214793 Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) Status SUSPENDED Phase PHASE2
NCT06202261 A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06161181 Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients Status COMPLETED Phase NA
NCT06157892 A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors Status RECRUITING Phase PHASE2
NCT06154590 Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor Status NOT_YET_RECRUITING Phase N/A
NCT06151249 Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy Status NOT_YET_RECRUITING Phase PHASE2
NCT06145399 A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer Status WITHDRAWN Phase EARLY_PHASE1